CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 82 enrolled
Drug / intervention
Wingspan Stent System with Gateway PTA Balloon Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00929383
NCT00929383N/ACompleted
CompareCT.gov

An International Registry of the Wingspan™ Stent System for the Treatment of Intracranial Atherosclerotic Stenosis

Stryker Neurovascular·observational·Posted Jun 29, 2009·Updated Jun 17, 2014

In Brief

An observational study evaluating Wingspan Stent System with Gateway PTA Balloon Catheter for Intracranial Atherosclerosis. Completed, enrolled 82 participants across 19 sites in 2 countries.

Detailed Summary

The IRISS study is designed to collect clinical and angiographic outcomes data when stenting intracranial atherosclerotic lesions using the Wingspan™ Stent System with Gateway™ PTA Balloon Catheter in routine clinical practice.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsIntracranial Atherosclerosis
CountriesFrance, Germany
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 29, 2009
Enrollment StartFeb 1, 2009
Primary CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 17.0 years ago

Interventions

Wingspan Stent System with Gateway PTA Balloon Catheterdevice

The Wingspan Stent System is used in conjunction with Gateway PTA Balloon Catheter to improve cerebral artery lumen diameter in patients with intracranial atherosclerotic disease. The Gateway Balloon Catheter is indicated for balloon dilation of the stenotic portion of intracranial arteries prior to stenting the artery for the purpose of improving intracranial perfusion.